查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475904

神经血管血栓切除设备市场:依产品类型,最终用户,地区-全球产业分析,规模,占有率,成长,趋势,预测2024-2031 年

Neurovascular Thrombectomy Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 194 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告详细分析了全球神经血管血栓切除设备市场。它对市场趋势、成长驱动因素/课题和新兴机会进行了深入分析，为神经血管血栓切除术领域提供了宝贵的见解。它提供了对市场的详细研究，并提供了绘製 2024 年至 2031 年市场轨蹟的关键统计数据和预测。

重要见解

  • 神经血管血栓切除装置市场规模（2024年）：7.417亿美元
  • 市场预测（2031年）：11.471亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：6.42%

神经血管血栓切除设备市场 - 报告范围：

神经血管血栓切除设备市场包括一系列用于治疗大血管闭塞引起的急性缺血性中风的重要设备。这些设备包括支架回收器、抽吸导管和其他旨在恢復闭塞脑动脉血流的辅助设备。该市场为医院、专科诊所和门诊手术中心提供先进的血栓清除解决方案，以改善患者的治疗效果并减少与中风相关的残疾。

市场驱动因素：

全球神经血管血栓切除设备市场由几个关键成长因素推动。缺血性中风的盛行率不断增加，以及人们对血管内血栓切除术益处的认识不断提高，正在推动对先进神经血管设备的需求。血栓切除装置的技术进步，例如下一代支架取栓器和抽吸系统的开发，将提高手术的有效性并扩大血管内治疗的患者群体。此外，医疗设备製造商、神经科医生和介入放射科医生之间的合作正在推动血栓清除设备的创新和采用，从而促进市场成长。

市场限制因素：

儘管预计成长前景良好，但神经血管血栓切除设备市场面临报销政策、程序复杂性和医生培训方面的课题。血栓切除术的报销范围因医疗保健系统而异，影响设备采用率和医院的投资决策，为市场扩张造成障碍。此外，执行神经介入手术所需的专业技能和基础设施需要对医疗专业人员进行持续的培训和教育，这限制了马苏地区血栓切除手术的广泛普及。

市场机会：

在技术创新、临床研究和医疗基础设施发展的推动下，神经血管血栓切除设备市场提供了利润丰厚的机会。远端中风网络、移动中风病房和院前中风分诊方案等新兴趋势将提高及时血栓切除治疗的可及性，并扩大神经血管设备的适用患者群体。此外，对人工智慧、机器人和数位健康解决方案的投资将能够提供个人化的中风护理，促进精准医疗的方法和优化治疗结果。此外，医疗器材公司、学术研究机构和监管机构之间的策略合作伙伴关係促进创新和监管合规，为市场成长和产品差异化铺平道路。

本报告解决的关键问题

  • 推动神经血管血栓切除设备市场全球成长的关键因素是什么？
  • 技术进步和临床研究如何影响神经血管血栓切除设备和手术的发展？
  • 神经介入设备领域的市场进入者面临哪些主要课题与机会？
  • 神经血管血栓切除装置在哪些地区和医疗机构最有成长潜力？
  • 在神经血管介入的竞争格局中，领先公司采取哪些策略来提高产品创新、市场渗透率和临床效果？

竞争资讯与经营策略：

全球神经血管血栓切除设备市场的主要参与者，包括跨国医疗器材公司、神经血管新创公司和学术研究机构，都专注于技术创新、临床证据产生和市场拓展，以获得竞争优势。这些公司投资研发，创造符合临床指引和病人偏好的新血栓清除设备、手术和中风治疗途径。此外，与中风中心、神经病学协会和医疗保健政策制定者的策略合作伙伴关係可以帮助设备製造商推进神经介入疗法的临床采用、报销和监管批准。此外，对上市后监测、真实世界证据产生和患者报告结果的关注将促进神经血管血栓切除术动态领域的持续改进和基于价值的创新。

主要公司简介

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • 其他

神经血管血栓切除装置市场细分

依产品

  • 支架回收器
  • 抽吸导管

依地区

  • 北美
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东/非洲

目录

第一章内容提要

第二章 市场介绍

  • 市场分类
  • 市场定义
  • 依产品类型划分的市场定义

第三章 世界经济展望

  • 依地区和国家划分的国内生产毛额产品类型（2006-2023）
  • 全球医疗保健市场指标

第四章市场机会分析

  • 宏观经济因素
  • 机会分析

第五章市场动态

  • 促进因素
  • 抑制因素
  • 机会
  • 趋势

第六章宏观经济假设

第七章 重大综合事项

  • 区域平均价格分析
  • 赎回场景
  • 主要规定

第8章北美神经血管血栓切除装置市场分析（2019-2023）与预测（2024-2031）

第9章拉丁美洲神经血管血栓切除设备市场分析（2019-2023）与预测（2024-2031）

第10章欧洲神经血管血栓切除装置市场分析（2019-2023）与预测（2024-2031）

第十一章 除中国以外的亚太地区神经血管血栓切除设备市场分析（2019-2023）和预测（2024-2031）

第十二章中国神经血管取栓设备市场分析（2019-2023）及预测（2024-2031）

  • 介绍
  • 过去的市场规模趋势分析（2019-2023）：依产品类型
    • 支架回收器
    • 抽吸导管
  • 市场规模预测（2024-2031）：依产品类型
  • 过去的市场规模趋势分析（2019-2023）：依最终用户
    • 医院
    • 神经导管实验室
    • 专科神经外科中心
  • 市场规模预测（2024-2031）：依最终用户划分
  • 市场吸引力分析
  • 加速器和约束：影响分析

第十三章中东和非洲神经血管血栓切除装置市场分析（2019-2023）和预测（2024-2031）

第 14 章预测因子：相关性与影响

第十五章预测的前提条件

第16章市场结构分析

  • 依层级划分的市场结构

第 17 章 竞争分析

  • 比赛仪表板
  • 衝突详情
    • Medtronic Plc
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Johnson & Johnson Services, Inc.
    • Penumbra Inc.
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Acandis GmbH
    • Argon Medical Inc

第十八章全球神经血管血栓切除设备市场分析（2019-2023）与预测（2024-2031）：依地区

  • 简介/主要发现
  • 过去的市场规模分析：依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区（不包括中国）
    • 中国
    • 中东/非洲
  • 市场规模预测：依地区
  • 依地区划分的市场吸引力分析

第十九章全球神经血管血栓切除设备市场分析（2019-2023）与预测（2024-2031）：依产品类型

  • 简介/主要发现
  • 过去的市场规模分析（2019-2023）：依产品类型
    • 支架回收器
    • 抽吸导管
  • 市场规模预测（2024-2031）：依产品类型
  • 依产品类型分析市场吸引力

第20章全球神经血管血栓切除设备市场分析（2019-2023）与预测（2024-2031）：依最终用户

  • 简介/主要发现
  • 过去的市场规模分析（2019-2023）：依最终用户
    • 医院
    • 神经导管实验室
    • 专科神经外科中心
  • 市场规模预测（2024-2031）：依最终用户划分
  • 最终用户的市场吸引力分析

第21章全球神经血管血栓切除设备市场分析（2019-2023）与机会评估（2024-2031）

  • 市场金额分析
  • 绝对数量机会

第22章假设和缩写

第23章研究方法论

简介目录
Product Code: PMRREP26176

Persistence Market Research presents an in-depth analysis of the global Neurovascular Thrombectomy Devices Market. Offering an in-depth analysis of market trends, growth drivers, challenges, and emerging opportunities, this study provides valuable insights into the neurovascular thrombectomy sector. It offers a detailed examination of the market, furnishing crucial statistics and projections delineating the market's trajectory from 2024 to 2031.

Key Insights:

  • Neurovascular Thrombectomy Devices Market Size (2024): USD 741.7 Million
  • Projected Market Value (2031): USD 1147.1 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.42%

Neurovascular Thrombectomy Devices Market - Report Scope:

The Neurovascular Thrombectomy Devices Market encompasses a range of critical devices utilized in the treatment of acute ischemic stroke caused by large vessel occlusion. These devices include stent retrievers, aspiration catheters, and other adjunctive devices designed to restore blood flow in occluded cerebral arteries. The market serves hospitals, specialty clinics, and ambulatory surgical centers, offering advanced thrombectomy solutions to improve patient outcomes and reduce disability associated with stroke.

Market Growth Drivers:

The global Neurovascular Thrombectomy Devices Market is driven by several key growth factors. The increasing incidence of ischemic stroke, coupled with growing awareness about the benefits of endovascular thrombectomy procedures, fuels demand for advanced neurovascular devices. Technological advancements in thrombectomy devices, such as the development of next-generation stent retrievers and aspiration systems, enhance procedural efficacy and expand the eligible patient population for endovascular treatment. Moreover, collaborative efforts between medical device manufacturers, neurologists, and interventional radiologists drive innovation and adoption of thrombectomy devices, contributing to market growth.

Market Restraints:

Despite promising growth prospects, the Neurovascular Thrombectomy Devices Market faces challenges related to reimbursement policies, procedural complexities, and physician training. Variations in reimbursement coverage for thrombectomy procedures across different healthcare systems impact device adoption rates and hospital investment decisions, posing a barrier to market expansion. Furthermore, the specialized skills and infrastructure required for performing neurointerventional procedures necessitate ongoing training and education for healthcare professionals, limiting widespread access to thrombectomy services in certain regions.

Market Opportunities:

The Neurovascular Thrombectomy Devices Market presents lucrative opportunities driven by technological innovation, clinical research, and healthcare infrastructure development. Emerging trends such as telestroke networks, mobile stroke units, and prehospital stroke triage protocols enhance access to timely thrombectomy treatment, expanding the addressable patient population for neurovascular devices. Additionally, investments in artificial intelligence, robotics, and digital health solutions enable personalized stroke care delivery, facilitating precision medicine approaches and optimizing treatment outcomes. Moreover, strategic collaborations between medical device companies, academic research institutions, and regulatory agencies foster innovation and regulatory compliance, paving the way for market growth and product differentiation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Neurovascular Thrombectomy Devices Market globally?
  • How are technological advancements and clinical research shaping the evolution of neurovascular thrombectomy devices and procedures?
  • What are the key challenges and opportunities facing market participants in the neurointerventional device segment?
  • Which geographic regions and healthcare settings offer the highest growth potential for neurovascular thrombectomy devices?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of neurovascular interventions?

Competitive Intelligence and Business Strategy:

Leading players in the global Neurovascular Thrombectomy Devices Market, including multinational medical device companies, neurovascular startups, and academic research institutions, focus on innovation, clinical evidence generation, and market expansion to gain a competitive edge. These companies invest in research and development to create novel thrombectomy devices, procedural techniques, and stroke care pathways aligned with clinical guidelines and patient preferences. Moreover, strategic partnerships with stroke centers, neurological societies, and healthcare policymakers enable device manufacturers to drive clinical adoption, reimbursement advocacy, and regulatory approval for neurointerventional therapies. Furthermore, emphasis on post-market surveillance, real-world evidence generation, and patient-reported outcomes fosters continuous improvement and value-based innovation in the dynamic landscape of neurovascular thrombectom

Key Companies Profiled:

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • Others.

Neurovascular Thrombectomy Devices Market Segmentation

By Product

  • Stent Retriever
  • Aspiration Catheter

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition
  • 2.3. Market Definition by Product Type

3. Global Economic Outlook

  • 3.1. Gross Domestic Product Type by Region & Country, 2006 - 2023
  • 3.2. Global Healthcare Market Indicators

4. Market Opportunity Analysis

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Opportunities
  • 5.4. Trends

6. Macroeconomic Assumptions

7. Key Inclusion

  • 7.1. Regional Average Pricing Analysis
  • 7.2. Reimbursement Scenario
  • 7.3. Key Regulations

8. North America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 8.4.1. Stent Retriever
    • 8.4.2. Aspiration Catheter
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 8.6.1. Hospitals
    • 8.6.2. Neuro-Catheterization Labs
    • 8.6.3. Specialized Neurosurgery Centers
  • 8.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 8.8. Market Attractiveness Analysis
    • 8.8.1. By Country
    • 8.8.2. By Product Type
    • 8.8.3. By End User
  • 8.9. Drivers and Restraints: Impact Analysis

9. Latin America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America
  • 9.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 9.5.1. Stent Retriever
    • 9.5.2. Aspiration Catheter
  • 9.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 9.7.1. Hospitals
    • 9.7.2. Neuro-Catheterization Labs
    • 9.7.3. Specialized Neurosurgery Centers
  • 9.8. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 9.9. Market Attractiveness Analysis
    • 9.9.1. By Country
    • 9.9.2. By Product Type
    • 9.9.3. By End User
  • 9.10. Drivers and Restraints: Impact Analysis

10. Europe Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 10.2.1. Germany
    • 10.2.2. U.K
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Russia
    • 10.2.7. Poland
    • 10.2.8. Rest of Western Europe
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 10.4.1. Stent Retriever
    • 10.4.2. Aspiration Catheter
  • 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 10.6.1. Hospitals
    • 10.6.2. Neuro-Catheterization Labs
    • 10.6.3. Specialized Neurosurgery Centers
  • 10.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Country
    • 10.8.2. By Product Type
    • 10.8.3. By End User
  • 10.9. Drivers and Restraints: Impact Analysis

11. Asia Pacific Excluding China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 11.2.1. Japan
    • 11.2.2. India
    • 11.2.3. Australia and New Zealand
    • 11.2.4. ASEAN
    • 11.2.5. Rest of Asia Pacific
  • 11.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 11.4.1. Stent Retriever
    • 11.4.2. Aspiration Catheter
  • 11.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 11.6.1. Hospitals
    • 11.6.2. Neuro-Catheterization Labs
    • 11.6.3. Specialized Neurosurgery Centers
  • 11.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Country
    • 11.8.2. By Product Type
    • 11.8.3. By End User
  • 11.9. Drivers and Restraints: Impact Analysis

12. China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 12.2.1. Stent Retriever
    • 12.2.2. Aspiration Catheter
  • 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 12.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 12.4.1. Hospitals
    • 12.4.2. Neuro-Catheterization Labs
    • 12.4.3. Specialized Neurosurgery Centers
  • 12.5. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By End User
  • 12.7. Drivers and Restraints: Impact Analysis

13. Middle East and Africa Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of Middle East and Africa
  • 13.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 13.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 13.4.1. Stent Retriever
    • 13.4.2. Aspiration Catheter
  • 13.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 13.6.1. Hospitals
    • 13.6.2. Neuro-Catheterization Labs
    • 13.6.3. Specialized Neurosurgery Centers
  • 13.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Country
    • 13.8.2. By Product Type
    • 13.8.3. By End User
  • 13.9. Drivers and Restraints: Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

  • 16.1. Market Structure by Tier

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competitors Deep Dive
    • 17.2.1. Medtronic Plc
      • 17.2.1.1. Overview
      • 17.2.1.2. Analyst Commentary
      • 17.2.1.3. Product Type and Technology Portfolio
      • 17.2.1.4. Channel Footprint
      • 17.2.1.5. Strategy
        • 17.2.1.5.1. Marketing Strategy
        • 17.2.1.5.2. Product Type Strategy
        • 17.2.1.5.3. Channel Strategy
    • 17.2.2. Stryker Corporation
      • 17.2.2.1. Overview
      • 17.2.2.2. Analyst Commentary
      • 17.2.2.3. Product Type and Technology Portfolio
      • 17.2.2.4. Channel Footprint
      • 17.2.2.5. Strategy
        • 17.2.2.5.1. Marketing Strategy
        • 17.2.2.5.2. Product Type Strategy
        • 17.2.2.5.3. Channel Strategy
    • 17.2.3. Teleflex Incorporated
      • 17.2.3.1. Overview
      • 17.2.3.2. Analyst Commentary
      • 17.2.3.3. Product Type and Technology Portfolio
      • 17.2.3.4. Channel Footprint
      • 17.2.3.5. Strategy
        • 17.2.3.5.1. Marketing Strategy
        • 17.2.3.5.2. Product Type Strategy
        • 17.2.3.5.3. Channel Strategy
    • 17.2.4. Terumo Corporation
      • 17.2.4.1. Overview
      • 17.2.4.2. Analyst Commentary
      • 17.2.4.3. Product Type and Technology Portfolio
      • 17.2.4.4. Channel Footprint
      • 17.2.4.5. Strategy
        • 17.2.4.5.1. Marketing Strategy
        • 17.2.4.5.2. Product Type Strategy
        • 17.2.4.5.3. Channel Strategy
    • 17.2.5. Johnson & Johnson Services, Inc.
      • 17.2.5.1. Overview
      • 17.2.5.2. Analyst Commentary
      • 17.2.5.3. Product Type and Technology Portfolio
      • 17.2.5.4. Channel Footprint
      • 17.2.5.5. Strategy
        • 17.2.5.5.1. Marketing Strategy
        • 17.2.5.5.2. Product Type Strategy
        • 17.2.5.5.3. Channel Strategy
    • 17.2.6. Penumbra Inc.
      • 17.2.6.1. Overview
      • 17.2.6.2. Analyst Commentary
      • 17.2.6.3. Product Type and Technology Portfolio
      • 17.2.6.4. Channel Footprint
      • 17.2.6.5. Strategy
        • 17.2.6.5.1. Marketing Strategy
        • 17.2.6.5.2. Product Type Strategy
        • 17.2.6.5.3. Channel Strategy
    • 17.2.7. Boston Scientific Corporation
      • 17.2.7.1. Overview
      • 17.2.7.2. Analyst Commentary
      • 17.2.7.3. Product Type and Technology Portfolio
      • 17.2.7.4. Channel Footprint
      • 17.2.7.5. Strategy
        • 17.2.7.5.1. Marketing Strategy
        • 17.2.7.5.2. Product Type Strategy
        • 17.2.7.5.3. Channel Strategy
    • 17.2.8. Edwards Lifesciences Corporation
      • 17.2.8.1. Overview
      • 17.2.8.2. Analyst Commentary
      • 17.2.8.3. Product Type and Technology Portfolio
      • 17.2.8.4. Channel Footprint
      • 17.2.8.5. Strategy
        • 17.2.8.5.1. Marketing Strategy
        • 17.2.8.5.2. Product Type Strategy
        • 17.2.8.5.3. Channel Strategy
    • 17.2.9. Acandis GmbH
      • 17.2.9.1. Overview
      • 17.2.9.2. Analyst Commentary
      • 17.2.9.3. Product Type and Technology Portfolio
      • 17.2.9.4. Channel Footprint
      • 17.2.9.5. Strategy
        • 17.2.9.5.1. Marketing Strategy
        • 17.2.9.5.2. Product Type Strategy
        • 17.2.9.5.3. Channel Strategy
    • 17.2.10. Argon Medical Inc
      • 17.2.10.1. Overview
      • 17.2.10.2. Analyst Commentary
      • 17.2.10.3. Product Type and Technology Portfolio
      • 17.2.10.4. Channel Footprint
      • 17.2.10.5. Strategy
        • 17.2.10.5.1. Marketing Strategy
        • 17.2.10.5.2. Product Type Strategy
        • 17.2.10.5.3. Channel Strategy

18. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031 By Region

  • 18.1. Introduction / Key Findings
  • 18.2. Historical Market Size (US$ Mn) Analysis By Region
    • 18.2.1. North America
    • 18.2.2. Latin America
    • 18.2.3. Europe
    • 18.2.4. Asia Pacific Excluding China
    • 18.2.5. China
    • 18.2.6. Middle East and Africa
  • 18.3. Market Size (US$ Mn) Forecast By Region
  • 18.4. Market Attractiveness Analysis By Region

19. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By Product Type

  • 19.1. Introduction/Key Finding
  • 19.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
    • 19.2.1. Stent Retriever
    • 19.2.2. Aspiration Catheter
  • 19.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 19.4. Market Attractiveness Analysis By Product Type

20. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 20.1. Introduction/Key Finding
  • 20.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
    • 20.2.1. Hospitals
    • 20.2.2. Neuro-Catheterization Labs
    • 20.2.3. Specialized Neurosurgery Centers
  • 20.3. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 20.4. Market Attractiveness Analysis By End User

21. Global Neurovascular Thrombectomy Devices Market Analysis 2019-2023 and Opportunity Assessment, 2024-2031

  • 21.1. Market Value Analysis (US$ Mn)
  • 21.2. Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology